Beta
11689

Study of the Level of Copeptin in Patients with Diabetic Retinopathy

Article

Last updated: 24 Dec 2024

Subjects

-

Tags

-

Abstract

Background: there were over 7.8 million cases of diabetes in Egypt in 2015. The prevalence of diabetic retinopathy in Egypt among adult diabetic patients in 2010 was around 20.5%. 90 percent of all cases of blindness from diabetes can be prevented.  Copeptin, a novel biomarker (a surrogate to arginine vasopressin was found to increase with diabetic nephropathy. Objectives: this study aimed to detect the level of copeptin in patients with diabetic retinopathy.Patients and Methods:  the study was conducted on individuals attending the diabetes and the ophthalmology outpatient clinics in Ain Shams University Hospitals between February and August 2017.  This study included 96 individuals and they were divided into 4 groups. Group I consisted of 24 patients with proliferative diabetic retinopaty (PDR), group II 24 patients with non proliferative diabetic retinopathy (NPDR), group III included 24 diabetic patients with no fundus abnormalities and group IV included 24 healthy non diabetic individuals. The individuals were subjected to full medical history taking, slit lamp biomicroscope fundus examination and the measurement of serum fasting blood sugar, 2 hour post prandial blood sugar, glycated hemoglobin, serum creatinine, serum copeptin and urinary albumin creatinine ratio. History taking included age, gender, type of diabetes, duration of diabetes, antidiabetic medications, any other medical comorbidities and pregnancy for females. Results: the present study showed a statistically significant rise in the level of copeptin in patients with PDR (Group I) and NPDR (Group II) when compared to those with no diabetic retinopathy (Group III) and the control group (Group IV) (P value <0.001). There was a statistically significant positive correlation with duration of diabetes (r = 0.589) and level of albumin/creatinine ratio (ACR) (r = 0.540) (P value <0.001) for both parameters. Conclusion: level of copeptin was found to be higher in patients with diabetic retinopathy, in patients with longer duration of diabetes and in those with elevated ACR. It was higher in diabetics in comparison to normal individuals.  

DOI

10.12816/0040142

Keywords

Copeptin, proliferative diabetic retinopathy, non proliferative diabetic retinopathy, Diabetes mellitus, biomarkers

Authors

First Name

Mohamed Reda

Last Name

Halawa

MiddleName

-

Affiliation

Department of Internal Medicine Department of Ophthalmology and Ophthalmic Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Email

-

City

-

Orcid

-

First Name

Abeer Ahmed

Last Name

Abdullah

MiddleName

-

Affiliation

Department of Internal Medicine , Department of Ophthalmology and Ophthalmic Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Email

-

City

-

Orcid

-

First Name

Evit Ezzat Eid

Last Name

Iskandar

MiddleName

-

Affiliation

Department of Internal Medicine Department of Ophthalmology and Ophthalmic Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Email

evit.iskandar@gmail.com

City

-

Orcid

-

Volume

69

Article Issue

1

Related Issue

2154

Issue Date

2017-10-01

Receive Date

2018-08-27

Publish Date

2017-10-01

Page Start

1,757

Page End

1,763

Print ISSN

1687-2002

Online ISSN

2090-7125

Link

https://ejhm.journals.ekb.eg/article_11689.html

Detail API

https://ejhm.journals.ekb.eg/service?article_code=11689

Order

29

Type

Original Article

Type Code

606

Publication Type

Journal

Publication Title

The Egyptian Journal of Hospital Medicine

Publication Link

https://ejhm.journals.ekb.eg/

MainTitle

Study of the Level of Copeptin in Patients with Diabetic Retinopathy

Details

Type

Article

Created At

22 Jan 2023